by
According to the Foreclaro Global Research, the
Global
Immunology Market size was valued at USD 98942.7 million in 2024. The report “Global Immunology
Market Segmentation By Drug Class (Monoclonal Antibodies (mAbs), Fusion
Proteins, Immunosuppressants, Corticosteroids, Other Small Molecules), By
Disease Indication (Rheumatoid Arthritis, Psoriasis & Psoriatic Arthritis, Inflammatory
Bowel Disease, Multiple Sclerosis, Systemic Lupus Erythematosus, Atopic
Dermatitis, Other Autoimmune & Inflammatory Diseases), By Drug Type (Biologics
& Biosimilars, Small Molecules), By Distribution Channel, Hospital
Pharmacies, Retail Pharmacies, Online Pharmacies)- Industry Trends and Forecast to 2033” gives a detailed insight into
current market dynamics and provides analysis on future market growth.
The global immunology market is experiencing
significant growth, driven by the rising prevalence of autoimmune and
inflammatory diseases, advancements in biotechnology, and the increasing
adoption of biologics and biosimilars. Immunology focuses on understanding and
treating disorders related to the immune system, including rheumatoid
arthritis, psoriasis, multiple sclerosis, and inflammatory bowel disease.
Pharmaceutical giants such as AbbVie, Roche, and Johnson & Johnson continue
to dominate the market through innovative monoclonal antibodies and targeted
therapies. Moreover, ongoing R&D investments, favorable regulatory
approvals, and expanding access to advanced treatments are further accelerating
market expansion. The integration of AI and precision medicine is enhancing
drug discovery and patient response prediction. However, high treatment costs
and biosimilar competition pose challenges. Overall, the market is expected to
sustain robust growth as emerging economies increase healthcare spending and
new biologics continue to transform the therapeutic landscape for
immune-mediated diseases.
Have any questions or need more information?
Click the link below to request a sample or make an inquiry before making your
purchase:
https://foreclaroglobalresearch.com/research-report/global-immunology-market
Global Immunology
Market Report Highlights
· Monoclonal
antibodies (mAbs) dominate the drug class segment, driven by strong demand for
targeted therapies and high clinical efficacy.
· Rheumatoid
arthritis and psoriasis remain the leading disease indications, supported by a
large patient base and continuous drug innovation.
· Biologics
and biosimilars account for the largest share of drug types, with biosimilars
gaining traction due to cost-effectiveness and expanding regulatory approvals.
· North
America leads the market, while Asia-Pacific is expected to register the
fastest growth due to rising healthcare investments and improving access to
advanced treatments.
· Strategic
collaborations, partnerships, and acquisitions by key players such as AbbVie,
Sanofi, Roche, and Biogen are shaping the competitive landscape and expanding
immunology pipelines.
Foreclaro
Global Research has segmented the Immunology Market report based on Drug Class,
Drug Indication, Drug Type, Distribution Channel, and region:
Immunology
Market, Drug Class Outlook (Revenue - USD Million, 2020 - 2033)
Monoclonal
Antibodies (mAbs)
Fusion
Proteins
Immunosuppressants
Corticosteroids
Other Small
Molecules
Immunology
Market, Diseases Indication Outlook (Revenue - USD Million, 2020 - 2033)
Rheumatoid
Arthritis
Psoriasis
& Psoriatic Arthritis
Inflammatory
Bowel Disease
Multiple
Sclerosis
Systemic
Lupus Erythematosus
Atopic
Dermatitis
Other
Autoimmune & Inflammatory Diseases
Immunology
Market, Drug Type Outlook (Revenue - USD Million, 2020 - 2033)
Biologics
& Biosimilars
Small
Molecules
Immunology
Market, Distribution Channel Outlook (Revenue - USD Million, 2020 - 2033)
Hospital
Pharmacies
Retail
Pharmacies
Online
Pharmacies
Immunology
Market, Regional Outlook (Revenue - USD Million, 2020 - 2033)
North
America
·
United
States
·
Canada
·
Mexico
Europe
·
United
Kingdom
·
Germany
·
France
·
Spain
·
Italy
·
Rest
of Europe
Asia
Pacific
·
China
·
India
·
Japan
·
Australia
·
South
Korea
·
Rest
of Asia Pacific
Latin
America
·
Brazil
·
Argentina
·
Rest
of Latin America
Middle East
& Africa
·
Saudi
Arabia
·
South
Africa
·
Rest
of MEA
Global Immunology Market Key Players
·
AbbVie Inc.
·
Johnson & Johnson
·
Amgen Inc.
·
F. Hoffmann-La Roche Ltd
·
Pfizer Inc.
·
Novartis International AG
·
Bristol-Myers Squibb Company
·
Merck & Co., Inc.
·
AstraZeneca PLC
·
Sanofi
·
GlaxoSmithKline plc
·
UCB S.A.
